Pierre Aman
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners.
Journal: Cellular & molecular biology letters
Published: March 18, 2025
Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 10, 2024
Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.
Journal: Journal of translational medicine
Published: January 10, 2024
Identification of genomic binding sites and direct target genes for the transcription factor DDIT3/CHOP.
Journal: Experimental cell research
Published: May 25, 2022
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo.
Journal: Biomedicines
Published: January 29, 2022
FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma.
Journal: Frontiers in oncology
Published: November 17, 2021
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.
Journal: Oncogenesis
Published: November 03, 2021
Total mRNA Quantification in Single Cells: Sarcoma Cell Heterogeneity.
Journal: Cells
Published: January 30, 2020
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
Journal: Scientific reports
Published: September 12, 2019
Requirement for YAP1 signaling in myxoid liposarcoma.
Journal: EMBO molecular medicine
Published: March 23, 2019
Last Updated: 09/26/2026